Aquestive Therapeutics, Inc

(NASDAQ:AQST)

Latest On Aquestive Therapeutics, Inc (AQST):

Date/Time Type Description Signal Details
2023-05-31 16:49 ESTNewsAquestive Therapeutics releases positive clinical data on anaphylm for anaphylaxis treatmentN/A
2023-05-03 20:59 ESTNewsAquestive Therapeutics, Inc. (AQST) Q1 2023 Earnings Call TranscriptN/A
2023-05-02 19:43 ESTNewsAquestive Therapeutics reports Q1 results, raises FY 2023 revenue guidanceN/A
2023-05-01 19:11 ESTNewsAquestive Therapeutics Q1 2023 Earnings PreviewN/A
2023-04-20 18:42 ESTNewsAquestive receives conditional FDA approval for proprietary name Anaphylm for lead candidate AQST-109N/A
2023-03-30 00:48 ESTNewsAquestive, Pharmanovia add territories to market seizure drug LibervantN/A
2023-03-09 13:04 ESTNewsAquestive upgraded at Wedbush after Q4 cash updateN/A
2023-03-08 22:19 ESTNewsAquestive Therapeutics, Inc. (AQST) Q4 2022 Earnings Call TranscriptN/A
2023-03-08 06:33 ESTNewsAquestive Therapeutics GAAP EPS of -$0.23 in-line, revenue of $10.68M beats by $0.26MN/A
2023-03-07 01:15 ESTNewsAquestive Therapeutics FY 2022 Earnings PreviewN/A
2022-11-29 20:46 ESTNewsAquestive Therapeutics: Going All-In On AQST-109N/A
2022-11-02 13:25 ESTNewsAquestive Therapeutics, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-02 13:25 ESTNewsAquestive Therapeutics, Inc. (AQST) Q3 2022 Earnings Call TranscriptN/A
2022-11-01 22:23 ESTNewsAquestive Therapeutics GAAP EPS of -$0.23 beats by $0.07, revenue of $11.46M beats by $0.42MN/A
2022-10-27 21:41 ESTNewsAquestive out licenses anti-seizure therapy to Assertio unitN/A
2022-10-11 12:20 ESTNewsAquestive Therapeutics receives positive FDA response for AQST-109 epinephrine for severe allergic reactionN/A
2022-09-28 15:09 ESTNewsAquestive Therapeutics, Pharmanovia ink licensing & supply pact for Libervant buccal filmN/A
2022-09-27 23:50 ESTNewsAquestive adds 20% as epinephrine sublingual film outperforms autoinjectorN/A
2022-09-05 13:08 ESTNewsAquestive Therapeutics: FDA Stymies Libervant LaunchN/A
2022-09-03 05:21 ESTNewsAquestive Therapeutics: Waiting To Buy After FDA Goes Halfway With LibervantN/A
2022-08-31 09:24 ESTNewsAquestive wins FDA tentative approval for ant-seizure medicationN/A
2022-08-29 08:49 ESTNewsAquestive Therapeutics: A First TakeN/A
2022-08-03 17:17 ESTNewsShares of Aquestive Therapeutics fall after Q2 revenue decreases, loss widensN/A
2022-08-03 17:16 ESTNewsAquestive Therapeutics, Inc. (AQST) CEO Dan Barber on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-03 02:59 ESTNewsAquestive Therapeutics GAAP EPS of -$0.36 in-line, revenue of $13.27M beats by $2.7MN/A
2022-08-01 22:03 ESTNewsAquestive Therapeutics Q2 2022 Earnings PreviewN/A
2022-06-20 08:15 ESTNewsAquestive Therapeutics (AQST) Investor Presentation - SlideshowN/A
2022-06-15 22:10 ESTNewsAquestive surges 31% after topline data for oral epinephrine candidateN/A
2022-06-06 16:29 ESTNewsAquestive Therapeutics to raise $8.5M in equity offeringN/A
2022-05-27 00:36 ESTNewsAquestive Therapeutics: Sell-Off Prompts A Change In TacticsN/A
2022-05-18 02:52 ESTNewsAquestive Therapeutics CEO Keith Kendall to resignN/A
2022-05-04 22:44 ESTNewsAquestive Therapeutics, Inc. (AQST) CEO Keith Kendall on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 03:15 ESTNewsAquestive Therapeutics GAAP EPS of -$0.32 beats by $0.09, revenue of $12.27M beats by $2.15MN/A
2022-05-03 09:20 ESTNewsAquestive Therapeutics Q1 2022 Earnings PreviewN/A
2022-04-12 23:33 ESTNewsAquestive stock falls 7% amid data from study of oral film AQST-109 for allergiesN/A
2022-03-18 11:46 ESTNewsAquestive Therapeutics nabs Fast Track designation for allergic reaction productN/A
2022-03-09 19:51 ESTNewsAquestive Therapeutics, Inc. (AQST) CEO Keith Kendall on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-09 03:06 ESTNewsAquestive Therapeutics GAAP EPS of -$1.85 misses by $0.36, revenue of $50.83M beats by $1.73MN/A
2022-03-08 09:11 ESTNewsAquestive Therapeutics FY 2021 Earnings PreviewN/A
2022-02-25 22:52 ESTNewsAquestive IND for AQST-109 cleared by FDA to enter trial for allergic reactionsN/A
2022-02-25 22:51 ESTNewsAquestive posts positive topline study data for epinephrine oral filmN/A
2022-02-22 18:06 ESTNewsAquestive Therapeutics: Discounted With An Incredible Risk-Reward For 2022N/A
2021-12-21 16:28 ESTNewsAquestive sheds a third after receiving FDA response for Libervant applicationN/A
2021-11-29 23:51 ESTNewsAquestive Therapeutics: Looking To End 2021 On A Bullish NoteN/A
2021-11-04 03:50 ESTNewsAquestive Therapeutics, Inc. (AQST) CEO Keith Kendall on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-03 07:52 ESTNewsAquestive Therapeutics EPS beats by $0.06, beats on revenueN/A
2021-11-02 12:00 ESTNewsAquestive Therapeutics Q3 2021 Earnings PreviewN/A
2021-10-25 12:52 ESTNewsAquestive Therapeutics posts topline data from early-stage trial of AQST-109N/A
2021-09-30 09:08 ESTNewsIntelGenx and Aquestive ink deal to market Tadalafil oral films in the U.S.N/A
2021-08-04 23:37 ESTNewsAquestive Therapeutics' (AQST) CEO Keith Kendall on Q2 2021 Results - Earnings Call TranscriptN/A

About Aquestive Therapeutics, Inc (AQST):

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; and Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation of epinephrine for the treatment of anaphylaxis; and AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.

AQST Quotes by TradingView

See Advanced Chart

General

  • Name Aquestive Therapeutics, Inc
  • Symbol AQST
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 187
  • Fiscal Year EndDecember
  • IPO Date2018-07-25
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.aquestive.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 3.96
  • Enterprise Value Revenue 4.45
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.76
  • Next Year EPS Estimate -$1.29
  • Next Quarter EPS Estimate -$0.43
  • Profit Margin -122%
  • Operating Margin -94%
  • Return on Assets -38%
  • Revenue 45.85 million
  • Earnings Per Share -$2.61
  • Revenue Per Share $1.36
  • Gross Profit 32.89 million
  • Quarterly Earnings Growth -56.5%
View More

Highlights

  • Market Capitalization 185.42 million
  • EBITDA -50208000
  • PE Ratio -16.04
  • Analyst Target Price $14.67
  • Book Value Per Share -$0.99
View More

Share Statistics

  • Shares Outstanding 36.21 million
  • Shares Float 34.05 million
  • % Held by Insiders 685%
  • % Held by Institutions 59.46%
  • Shares Short 2.63 million
  • Shares Short Prior Month 1.25 million
  • Short Ratio 2.45
  • Short % of Float 13%
  • Short % of Shares Outstanding 8%
View More

Technicals

  • Beta 3.72
  • 52 Week High $9.47
  • 52 Week Low $1.75
  • 50 Day Moving Average 5.41
  • 200 Day Moving Average 6.06
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Aquestive Therapeutics, Inc (AQST) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Aquestive Therapeutics, Inc (AQST) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-09$7.15 million-$0.61-$0.28-117.86%
2020-09-302020-11-04$N/A-$0.49-$0.43-13.43%
2020-06-302020-08-04$N/A-$0.07-$0.4484.21%
2020-03-312020-05-05$8.77 million-$0.49-$0.48-2.51%
2019-12-312020-03-11$16.42 million-$0.48-$0.40-21.21%
2019-09-302019-11-05$12.42 million-$0.54-$0.7224.48%
2019-06-302019-08-06$11.13 million-$0.82-$0.66-24.24%
2019-03-312019-05-08$12.64 million-$0.59-$0.49-20.41%
2018-12-312019-03-14$16.82 million-$0.56-$0.56-0.9%
2018-09-302018-11-06$13.27 million-$0.64-$0.34-90.08%
2018-06-302018-09-04$13.93 million-$0.47-$0.30-56.33%

Aquestive Therapeutics, Inc (AQST) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Aquestive Therapeutics, Inc (AQST) Chart:

Aquestive Therapeutics, Inc (AQST) News:

Below you will find a list of latest news for Aquestive Therapeutics, Inc (AQST) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Aquestive Therapeutics, Inc (AQST) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-09-200.53.2CALL1 21056.5TRUE3.20
2024-09-201.50CALL0 0984.18TRUE00
2024-09-2020CALL0 0644.05TRUE00
2024-09-202.51CALL0 20TRUE00
2024-09-2031.4CALL0 1180TRUE00
2024-09-203.51.06CALL0 20TRUE00
2024-09-2040.8CALL0 389093.01TRUE00
2024-09-204.50.35CALL0 2930FALSE00
2024-09-2050.15CALL0 11910FALSE00
2024-09-205.50.15CALL0 460FALSE00
2024-09-207.50.05CALL0 50FALSE00
2024-09-200.50PUT0 00FALSE00
2024-09-201.50PUT0 00FALSE00
2024-09-2020PUT0 00FALSE00
2024-09-202.50.05PUT0 1500FALSE00
2024-09-2030.08PUT0 1880FALSE00
2024-09-203.50.12PUT50 157122.41FALSE0.071.4
2024-09-2040.2PUT12 25589.04FALSE0.20
2024-09-204.50.5PUT0 59349.97TRUE00
2024-09-2050.8PUT0 20TRUE00
2024-09-205.50PUT0 00TRUE00
2024-09-207.50PUT0 0597.8TRUE00
2024-10-182.50CALL0 00TRUE00
2024-10-1850.35CALL10 3692109.5FALSE0.350
2024-10-187.50.1CALL0 600FALSE00
2024-10-182.50PUT0 00FALSE00
2024-10-1850PUT0 00TRUE00
2024-10-187.50PUT0 0159TRUE00
2024-11-150.50CALL0 0850.26TRUE00
2024-11-1512.55CALL0 0932.26TRUE00
2024-11-151.52.3CALL0 40TRUE00
2024-11-1522.05CALL0 90212.33TRUE00
2024-11-152.52.16CALL0 220105.91TRUE00
2024-11-1531.75CALL0 12430TRUE00
2024-11-153.51.45CALL0 5190TRUE00
2024-11-1541.1CALL0 59882.49TRUE00
2024-11-154.50.7CALL0 22080.3FALSE00
2024-11-1550.55CALL0 1148105.06FALSE00
2024-11-155.50.6CALL0 248118.59FALSE00
2024-11-157.50.1CALL0 1111115.23FALSE00
2024-11-15100.05CALL0 10210FALSE00
2024-11-150.50PUT0 00FALSE00
2024-11-1510PUT0 00FALSE00
2024-11-151.50PUT0 00FALSE00
2024-11-1520.2PUT0 210FALSE00
2024-11-152.50.25PUT1 244150.59FALSE0.151.5
2024-11-1530.17PUT2 39795.43FALSE0.170
2024-11-153.50.3PUT0 68105.84FALSE00
2024-11-1540.45PUT0 10088.65FALSE00
2024-11-154.50.85PUT0 2620TRUE00
2024-11-1551PUT0 244139.24TRUE00
2024-11-155.50PUT0 00TRUE00
2024-11-157.54.12PUT0 126189.72TRUE00
2024-11-15105.9PUT0 0237.38TRUE00
2025-02-210.55CALL0 6262.44TRUE00
2025-02-2113.15CALL0 1306.35TRUE00
2025-02-211.53CALL0 10164.68TRUE00
2025-02-2122.35CALL0 2205.74TRUE00
2025-02-212.51.92CALL2 30287.14TRUE1.920
2025-02-2131.5CALL0 6208.62TRUE00
2025-02-213.51.25CALL0 890TRUE00
2025-02-2141.4CALL0 49161.77TRUE00
2025-02-214.51.16CALL0 530FALSE00
2025-02-2150.77CALL5 32390.06FALSE0.770
2025-02-215.50.69CALL0 22990.75FALSE00
2025-02-217.50.5CALL0 14695.88FALSE00
2025-02-210.50.35PUT0 10FALSE00
2025-02-2110PUT0 00FALSE00
2025-02-211.50PUT0 00FALSE00
2025-02-2120PUT0 00FALSE00
2025-02-212.50.7PUT0 30FALSE00
2025-02-2130.35PUT0 1650FALSE00
2025-02-213.50.51PUT0 10FALSE00
2025-02-2140.8PUT0 23585.48FALSE00
2025-02-214.51.15PUT0 101115.1TRUE00
2025-02-2151.5PUT0 210TRUE00
2025-02-215.50PUT0 00TRUE00
2025-02-217.50PUT0 078.06TRUE00

Latest AQST Trades:

Date Shares Price
Jun 13, 2022 7:01 PM EST100$0.8297
Jun 13, 2022 7:01 PM EST100$0.8297
Jun 13, 2022 7:31 PM EST100$0.8055
Jun 13, 2022 7:34 PM EST2$0.8055
Jun 13, 2022 7:54 PM EST100$0.8177

Aquestive Therapeutics, Inc (AQST) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920006105/0001214659-20-006105-index.htm
2019-09-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1398733/000000000019013614/0000000000-19-013614-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1398733/000089742319000028/0000897423-19-000028-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1398733/000089742320000050/0000897423-20-000050-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1398733/000110465920053373/0001104659-20-053373-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1398733/000110465920053375/0001104659-20-053375-index.htm
2020-06-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1398733/000110465920069816/0001104659-20-069816-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118039945/0001140361-18-039945-index.htm
2018-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036118041664/0001140361-18-041664-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036118042519/0001140361-18-042519-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1398733/000114036118042522/0001140361-18-042522-index.htm
2018-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118043649/0001140361-18-043649-index.htm
2018-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118043651/0001140361-18-043651-index.htm
2018-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118043653/0001140361-18-043653-index.htm
2018-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118043656/0001140361-18-043656-index.htm
2018-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118043665/0001140361-18-043665-index.htm
2018-11-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118043897/0001140361-18-043897-index.htm
2018-11-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118044032/0001140361-18-044032-index.htm
2018-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118044399/0001140361-18-044399-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118044533/0001140361-18-044533-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118044536/0001140361-18-044536-index.htm
2018-12-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118044723/0001140361-18-044723-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118044868/0001140361-18-044868-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118044870/0001140361-18-044870-index.htm
2018-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036118044886/0001140361-18-044886-index.htm
2018-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036118044950/0001140361-18-044950-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036118045429/0001140361-18-045429-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036119000279/0001140361-19-000279-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000114036119000283/0001140361-19-000283-index.htm
2019-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119004909/0001140361-19-004909-index.htm
2019-03-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1398733/000114036119004934/0001140361-19-004934-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119008622/0001140361-19-008622-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1398733/000114036119008649/0001140361-19-008649-index.htm
2019-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119011182/0001140361-19-011182-index.htm
2019-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119012961/0001140361-19-012961-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1398733/000114036119014361/0001140361-19-014361-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119014365/0001140361-19-014365-index.htm
2019-09-11S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1398733/000114036119016535/0001140361-19-016535-index.htm
2019-09-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1398733/000114036119016686/0001140361-19-016686-index.htm
2019-09-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1398733/000114036119016847/0001140361-19-016847-index.htm
2019-09-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1398733/000114036119016849/0001140361-19-016849-index.htm
2019-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119017521/0001140361-19-017521-index.htm
2019-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119018473/0001140361-19-018473-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119019846/0001140361-19-019846-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1398733/000114036119019856/0001140361-19-019856-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119020406/0001140361-19-020406-index.htm
2019-11-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119021280/0001140361-19-021280-index.htm
2019-11-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119021505/0001140361-19-021505-index.htm
2019-12-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119021749/0001140361-19-021749-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119022101/0001140361-19-022101-index.htm
2019-12-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1398733/000114036119022296/0001140361-19-022296-index.htm
2019-12-16424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1398733/000114036119022649/0001140361-19-022649-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036119022653/0001140361-19-022653-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120000604/0001140361-20-000604-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120000658/0001140361-20-000658-index.htm
2020-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120002434/0001140361-20-002434-index.htm
2020-02-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120002638/0001140361-20-002638-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120005493/0001140361-20-005493-index.htm
2020-03-1110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1398733/000114036120005499/0001140361-20-005499-index.htm
2020-03-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1398733/000114036120005609/0001140361-20-005609-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120006442/0001140361-20-006442-index.htm
2020-04-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120009240/0001140361-20-009240-index.htm
2020-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120009673/0001140361-20-009673-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120010722/0001140361-20-010722-index.htm
2020-05-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1398733/000114036120010724/0001140361-20-010724-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120012242/0001140361-20-012242-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120014126/0001140361-20-014126-index.htm
2020-06-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120014990/0001140361-20-014990-index.htm
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120015330/0001140361-20-015330-index.htm
2020-08-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120017448/0001140361-20-017448-index.htm
2020-08-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1398733/000114036120017454/0001140361-20-017454-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120017885/0001140361-20-017885-index.htm
2020-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120021614/0001140361-20-021614-index.htm
2020-11-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120024385/0001140361-20-024385-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1398733/000114036120024551/0001140361-20-024551-index.htm
2020-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1398733/000114036120024555/0001140361-20-024555-index.htm
2019-09-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1398733/000117266119001901/0001172661-19-001901-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1398733/000117494719000605/0001174947-19-000605-index.htm
2019-04-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1398733/000117494719000606/0001174947-19-000606-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1398733/000119312519041022/0001193125-19-041022-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1398733/000119312520038109/0001193125-20-038109-index.htm
2019-01-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919000168/0001214659-19-000168-index.htm
2019-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919000170/0001214659-19-000170-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919001723/0001214659-19-001723-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919001724/0001214659-19-001724-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919001748/0001214659-19-001748-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919001749/0001214659-19-001749-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919001750/0001214659-19-001750-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919001751/0001214659-19-001751-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919001752/0001214659-19-001752-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919001753/0001214659-19-001753-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919001754/0001214659-19-001754-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919002418/0001214659-19-002418-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919002419/0001214659-19-002419-index.htm
2019-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919003383/0001214659-19-003383-index.htm
2019-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919003979/0001214659-19-003979-index.htm
2019-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919003980/0001214659-19-003980-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919004243/0001214659-19-004243-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919004244/0001214659-19-004244-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919004245/0001214659-19-004245-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919004246/0001214659-19-004246-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919004247/0001214659-19-004247-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919004250/0001214659-19-004250-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919004458/0001214659-19-004458-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919004459/0001214659-19-004459-index.htm
2019-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919005182/0001214659-19-005182-index.htm
2019-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919005183/0001214659-19-005183-index.htm
2019-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919005184/0001214659-19-005184-index.htm
2019-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm
2019-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919005414/0001214659-19-005414-index.htm
2019-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919005489/0001214659-19-005489-index.htm
2019-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919005618/0001214659-19-005618-index.htm
2019-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919005619/0001214659-19-005619-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919005969/0001214659-19-005969-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919006187/0001214659-19-006187-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919006188/0001214659-19-006188-index.htm
2019-12-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919007535/0001214659-19-007535-index.htm
2019-12-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465919007536/0001214659-19-007536-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920000018/0001214659-20-000018-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920000041/0001214659-20-000041-index.htm
2020-02-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920001859/0001214659-20-001859-index.htm
2020-02-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920001860/0001214659-20-001860-index.htm
2020-02-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920001881/0001214659-20-001881-index.htm
2020-02-264/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920001882/0001214659-20-001882-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002183/0001214659-20-002183-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002184/0001214659-20-002184-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002746/0001214659-20-002746-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002747/0001214659-20-002747-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002748/0001214659-20-002748-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002749/0001214659-20-002749-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002750/0001214659-20-002750-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002751/0001214659-20-002751-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002752/0001214659-20-002752-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002753/0001214659-20-002753-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920002754/0001214659-20-002754-index.htm
2020-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920003145/0001214659-20-003145-index.htm
2020-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920003146/0001214659-20-003146-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920003962/0001214659-20-003962-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920004018/0001214659-20-004018-index.htm
2020-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920004314/0001214659-20-004314-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920005338/0001214659-20-005338-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920005339/0001214659-20-005339-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920005427/0001214659-20-005427-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920005755/0001214659-20-005755-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920005756/0001214659-20-005756-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920005757/0001214659-20-005757-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920005758/0001214659-20-005758-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920005759/0001214659-20-005759-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920005776/0001214659-20-005776-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920006104/0001214659-20-006104-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920006105/0001214659-20-006105-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1398733/000121465920007366/0001214659-20-007366-index.htm
2019-09-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1398733/999999999519002118/9999999995-19-002118-index.htm

Aquestive Therapeutics, Inc (AQST) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aquestive Therapeutics, Inc (AQST). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 685%
Institutional Ownership: 5946%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-11-27LORI J BRAENDERGeneral CounselBuy1,000.0010.5710,570.001,000.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118044032/0001140361-18-044032-index.htm
2018-09-30Keith J KendallCEO and PresidentBuy329.001,008,391.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118039945/0001140361-18-039945-index.htm
2018-11-21Alexander Mark SchobelChief Innovation/Tech OfficerBuy1,000.0010.2510,250.001,009,229.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118043656/0001140361-18-043656-index.htm
2018-12-06Alexander Mark SchobelChief Innovation/Tech OfficerBuy2,000.008.6917,380.001,018,624.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118044870/0001140361-18-044870-index.htm
2019-08-27Daniel BarberSVP-Chief Operating OfficerBuy2,000.003.997,980.00101,959.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005489/0001214659-19-005489-index.htm
2018-12-10Alexander Mark SchobelChief Innovation/Tech OfficerBuy1,000.007.787,780.001,019,624.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118044950/0001140361-18-044950-index.htm
2018-12-31Alexander Mark SchobelChief Innovation/Tech OfficerBuy329.001,019,953.00https://www.sec.gov/Archives/edgar/data/1398733/000114036119000283/0001140361-19-000283-index.htm
2020-04-29Alexander Mark SchobelChief Innovation/Tech OfficerSell40,000.004.50180,000.001,022,113.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920003962/0001214659-20-003962-index.htm
2018-11-30Alexander Mark SchobelChief Innovation/Tech OfficerBuy14,572.001,023,801.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118044536/0001140361-18-044536-index.htm
2019-03-31Alexander Mark SchobelChief Innovation/Tech OfficerBuy329.001,027,971.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919002419/0001214659-19-002419-index.htm
2019-02-28Alexander Mark SchobelChief Innovation/Tech OfficerBuy14,572.001,034,363.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919001723/0001214659-19-001723-index.htm
2019-06-30Alexander Mark SchobelChief Innovation/Tech OfficerBuy329.001,036,018.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919004458/0001214659-19-004458-index.htm
2019-05-31Alexander Mark SchobelChief Innovation/Tech OfficerBuy14,572.001,042,280.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919003980/0001214659-19-003980-index.htm
2019-09-30Alexander Mark SchobelChief Innovation/Tech OfficerBuy329.001,044,310.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919006188/0001214659-19-006188-index.htm
2019-12-31Alexander Mark SchobelChief Innovation/Tech OfficerBuy329.001,044,494.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920000041/0001214659-20-000041-index.htm
2019-08-31Alexander Mark SchobelChief Innovation/Tech OfficerBuy14,572.001,050,441.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005618/0001214659-19-005618-index.htm
2019-11-30Alexander Mark SchobelChief Innovation/Tech OfficerBuy14,572.001,058,737.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919007535/0001214659-19-007535-index.htm
2020-03-31Alexander Mark SchobelChief Innovation/Tech OfficerBuy329.001,062,210.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920003145/0001214659-20-003145-index.htm
2020-02-29Alexander Mark SchobelChief Innovation/Tech OfficerBuy14,572.001,066,947.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920002184/0001214659-20-002184-index.htm
2019-08-09LORI J BRAENDERSVP, General CounselBuy10,000.004.0740,747.0011,000.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005183/0001214659-19-005183-index.htm
2018-11-21Ken W. MarshallCommercial LeaderBuy1,445.0010.1514,666.751,445.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118044399/0001140361-18-044399-index.htm
2018-11-21John T. MaxwellSVP-Chief Financial OfficerBuy10,000.009.8098,000.00148,614.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118043653/0001140361-18-043653-index.htm
2020-08-18John T. MaxwellSVP-Chief Financial OfficerSell3,000.008.0024,000.00150,614.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920007366/0001214659-20-007366-index.htm
2018-12-06John T. MaxwellSVP-Chief Financial OfficerBuy5,000.008.8744,350.00153,614.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118044723/0001140361-18-044723-index.htm
2019-08-19James S ScibettaDirectorBuy10,761.003.7740,547.4519,425.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005414/0001214659-19-005414-index.htm
2020-03-16LORI J BRAENDERSVP, General CounselBuy14,000.001.5421,624.4025,000.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920002747/0001214659-20-002747-index.htm
2019-08-20James S ScibettaDirectorBuy11,310.003.8043,000.6230,735.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005414/0001214659-19-005414-index.htm
2019-08-21James S ScibettaDirectorBuy900.003.813,429.0031,635.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005414/0001214659-19-005414-index.htm
2018-11-21Peter E. BoydSVP-Operations/Value DeliveryBuy200.009.981,996.0049,639.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118043649/0001140361-18-043649-index.htm
2019-08-12Peter E. BoydSVP-Bus. Process & Info. Tech.Buy600.003.812,286.0050,239.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005182/0001214659-19-005182-index.htm
2020-03-16Peter E. BoydSVP-Bus. Process & Info. Tech.Buy2,000.001.503,000.0052,239.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920002746/0001214659-20-002746-index.htm
2018-11-21Keith J KendallCEO and PresidentBuy6,000.0010.1761,020.00618,189.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118043651/0001140361-18-043651-index.htm
2018-11-23Keith J KendallCEO and PresidentBuy1,950.009.9019,305.00620,139.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118043651/0001140361-18-043651-index.htm
2018-11-27Keith J KendallCEO and PresidentBuy1,000.009.879,870.00621,139.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118043897/0001140361-18-043897-index.htm
2018-12-31Keith J KendallCEO and PresidentBuy329.00628,863.00https://www.sec.gov/Archives/edgar/data/1398733/000114036119000279/0001140361-19-000279-index.htm
2018-11-30Keith J KendallCEO and PresidentBuy14,572.00635,711.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118044533/0001140361-18-044533-index.htm
2019-03-31Keith J KendallCEO and PresidentBuy329.00638,877.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919002418/0001214659-19-002418-index.htm
2020-06-04Keith J KendallCEO and PresidentSell50,000.005.11255,310.00638,964.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920005427/0001214659-20-005427-index.htm
2020-06-30Keith J KendallCEO and PresidentBuy333.00639,297.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920006104/0001214659-20-006104-index.htm
2019-02-28Keith J KendallCEO and PresidentBuy14,572.00643,273.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919001724/0001214659-19-001724-index.htm
2019-06-30Keith J KendallCEO and PresidentBuy329.00646,735.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919004459/0001214659-19-004459-index.htm
2019-08-09Keith J KendallCEO and PresidentBuy2,000.003.847,680.00648,581.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm
2019-08-09Keith J KendallCEO and PresidentBuy1,000.003.933,925.00649,581.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm
2019-08-09Keith J KendallCEO and PresidentBuy2,000.004.007,990.00651,581.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm
2019-08-13Keith J KendallCEO and PresidentBuy1,000.004.054,045.00652,581.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm
2019-05-31Keith J KendallCEO and PresidentBuy14,572.00653,186.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919003979/0001214659-19-003979-index.htm
2019-08-14Keith J KendallCEO and PresidentBuy1,000.003.703,697.00653,581.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm
2019-08-14Keith J KendallCEO and PresidentBuy1,000.003.653,650.00654,581.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005387/0001214659-19-005387-index.htm
2019-09-30Keith J KendallCEO and PresidentBuy329.00662,806.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919006187/0001214659-19-006187-index.htm
2019-12-31Keith J KendallCEO and PresidentBuy329.00662,985.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920000018/0001214659-20-000018-index.htm
2019-08-31Keith J KendallCEO and PresidentBuy14,572.00669,153.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005619/0001214659-19-005619-index.htm
2019-11-30Keith J KendallCEO and PresidentBuy14,572.00677,228.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919007536/0001214659-19-007536-index.htm
2020-03-31Keith J KendallCEO and PresidentBuy329.00680,983.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920003146/0001214659-20-003146-index.htm
2020-02-29Keith J KendallCEO and PresidentBuy14,572.00685,383.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920002183/0001214659-20-002183-index.htm
2020-05-31Keith J KendallCEO and PresidentBuy14,572.00695,456.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920005338/0001214659-20-005338-index.htm
2018-11-26Theresa WoodSVP-HR and Org. DevelopmentBuy500.0010.345,170.0079,765.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118043665/0001140361-18-043665-index.htm
2019-08-09Theresa WoodSVP-HR and Org. DevelopmentBuy1,000.003.993,990.0080,765.00https://www.sec.gov/Archives/edgar/data/1398733/000121465919005184/0001214659-19-005184-index.htm
2020-05-08Alexander Mark SchobelChief Innovation/Tech OfficerSell40,000.005.00200,000.00902,113.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920004314/0001214659-20-004314-index.htm
2020-06-30Alexander Mark SchobelChief Innovation/Tech OfficerBuy333.00912,886.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920006105/0001214659-20-006105-index.htm
2020-05-31Alexander Mark SchobelChief Innovation/Tech OfficerBuy14,572.00916,685.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920005339/0001214659-20-005339-index.htm
2020-04-27Alexander Mark SchobelChief Innovation/Tech OfficerSell40,000.004.00160,000.00942,113.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920004018/0001214659-20-004018-index.htm
2020-04-14Alexander Mark SchobelChief Innovation/Tech OfficerSell40,000.003.70148,000.00982,113.00https://www.sec.gov/Archives/edgar/data/1398733/000121465920004018/0001214659-20-004018-index.htm
2018-12-10Daniel BarberSVP-Chief Strategy/Dev OfficerBuy1,000.008.008,000.0099,959.00https://www.sec.gov/Archives/edgar/data/1398733/000114036118044868/0001140361-18-044868-index.htm